• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

CTI BioPharma - Articles and news items

Tosedostat in combination with low dose cytarabine achieves primary endpoint in Phase 2 study

Industry news / 15 June 2015 / Victoria White

CTI BioPharma has announced findings from a Phase 2 trial of tosedostat in combination with low dose cytarabine in patients with acute myeloid leukaemia…

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringFIND OUT MORE
+ +